Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Could oral fluid be used to evaluate anti-hepatitis A virus status in individuals living in difficult-to-access areas?

Tourinho RS, de Almeida AJ, Amado LA, Villar LM, Castro AR, de Paula VS.

Vaccine. 2012 Oct 5;30(45):6421-6. doi: 10.1016/j.vaccine.2012.08.015. Epub 2012 Aug 19.

2.

Cross-Sectional Study of Hepatitis A Virus Infection in the Pantanal Population before Vaccine Implementation in Brazil: Usage of Non-Invasive Specimen Collection.

Tourinho RS, de Almeida AJ, Villar LM, Murat PG, Capelin GJ, Castro AR, de Paula VS.

Int J Environ Res Public Health. 2015 Jun 30;12(7):7357-69. doi: 10.3390/ijerph120707357.

3.

Importance of the cutoff ratio for detecting antibodies against hepatitis A virus in oral fluids by enzyme immunoassay.

Tourinho RS, Amado LA, Villar LM, Sampaio DV, Moraes AC, Rodrigues do Ó KM, Gaspar AM, de Paula VS.

J Virol Methods. 2011 May;173(2):169-74. doi: 10.1016/j.jviromet.2011.01.014. Epub 2011 Feb 3.

PMID:
21295610
5.

A comparison of oral fluid collection devices for use in the surveillance of virus diseases in children.

Vyse AJ, Cohen BJ, Ramsay ME.

Public Health. 2001 May;115(3):201-7.

PMID:
11429716
6.

A population-based seroprevalence study of hepatitis A virus using oral fluid in England and Wales.

Morris-Cunnington MC, Edmunds WJ, Miller E, Brown DW.

Am J Epidemiol. 2004 Apr 15;159(8):786-94.

7.

Nationwide canadian study of hepatitis a antibody prevalence among children eight to thirteen years old.

Duval B, De Serres G, Ochnio J, Scheifele D, Gîlca V.

Pediatr Infect Dis J. 2005 Jun;24(6):514-9.

PMID:
15933561
8.
9.

A nationwide survey of past hepatitis A infections among Canadian adults.

Scheifele DW, De Serres G, Gilca V, Duval B, Milner R, Ho M, Ochnio JJ.

Vaccine. 2010 Jul 19;28(32):5174-8. doi: 10.1016/j.vaccine.2010.05.076. Epub 2010 Jun 15.

PMID:
20558251
10.

Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots.

Judd A, Parry J, Hickman M, McDonald T, Jordan L, Lewis K, Contreras M, Dusheiko G, Foster G, Gill N, Kemp K, Main J, Murray-Lyon I, Nelson M.

J Med Virol. 2003 Sep;71(1):49-55.

PMID:
12858408
11.

Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?

Villar LM, de Melo MM, Calado IA, de Almeida AJ, Lampe E, Gaspar AM.

J Gastroenterol Hepatol. 2009 Feb;24(2):238-42. doi: 10.1111/j.1440-1746.2008.05575.x.

PMID:
19215334
12.

Importance of collection methods and stability of oral fluid samples for hepatitis B surface antigen detection.

de Paula Scalioni L, Cruz HM, de Paula VS, Corrêia Oliveira J, Tourinho Dos Santos R, Motta-Castro AR, Murat PG, Villela-Nogueira CA, Lewis-Ximenez LL, Lampe E, Villar LM.

J Clin Lab Anal. 2013 May;27(3):186-94. doi: 10.1002/jcla.21582. Epub 2013 Feb 25.

PMID:
23440736
13.

Exposure to multiple subgenotypes of hepatitis A virus during an outbreak using matched serum and saliva specimens.

Amado LA, Villar LM, de Paula VS, Pinto MA, Gaspar AM.

J Med Virol. 2011 May;83(5):768-75. doi: 10.1002/jmv.22045.

PMID:
21412786
14.

Detection of hepatitis A, B, and C virus-specific antibodies using oral fluid for epidemiological studies.

Amado LA, Villar LM, de Paula VS, de Almeida AJ, Gaspar AM.

Mem Inst Oswaldo Cruz. 2006 Mar;101(2):149-55.

PMID:
16830707
15.

Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.

Ceyhan M, Yildirim I, Kurt N, Uysal G, Dikici B, Ecevit C, Aydogan A, Koc A, Yasa O, Köseoğlu M, Onal K, Hacimustafaoglu M, Celebi S.

J Viral Hepat. 2008 Oct;15 Suppl 2:69-72. doi: 10.1111/j.1365-2893.2008.01034.x.

PMID:
18837839
16.

The use of dried blood spots for assessing antibody response to hepatitis A virus after natural infection and vaccination.

Melgaço JG, Pinto MA, Rocha AM, Freire M, Gaspar LP, Lima SM, Cruz OG, Vitral CL.

J Med Virol. 2011 Feb;83(2):208-17. doi: 10.1002/jmv.21973.

PMID:
21181914
17.

Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.

Gutiérrez Domingo I, Pascasio Acevedo JM, Alcalde Vargas A, Ramos Cuadra A, Ferrer Ríos MT, Sousa Martín JM, Sayago Mota M, Giráldez Gallego A, Suárez Artacho G.

Transplant Proc. 2012 Jul-Aug;44(6):1502-4. doi: 10.1016/j.transproceed.2012.05.020.

PMID:
22841196
18.

Participant-collected, mail-delivered oral fluid specimens can replace traditional serosurveys: a demonstration-of-feasibility survey of hepatitis A virus-specific antibodies in adults.

Ochnio JJ, Scheifele DW, Marion SA, Bigham M, Patrick DM, Ho M, Mozel M.

Can J Public Health. 2007 Jan-Feb;98(1):37-40.

PMID:
17278676
19.

Hepatitis a in Korea: epidemiological shift and call for vaccine strategy.

Lee D, Cho YA, Park Y, Hwang JH, Kim JW, Kim NY, Lee DH, Lee W, Jeong SH.

Intervirology. 2008;51(2):70-4. doi: 10.1159/000127428. Epub 2008 Apr 22.

PMID:
18434743
20.

Comparison between serum and saliva for the detection of hepatitis A virus RNA.

Amado LA, Villar LM, de Paula VS, Gaspar AM.

J Virol Methods. 2008 Mar;148(1-2):74-80. Epub 2007 Dec 21.

PMID:
18160140
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk